Nuvation Bio Inc. (NUVB) is a pharmaceutical preparations company incorporated in DE, listed on the NYSE. With a market capitalization of $2.0 billion, Nuvation Bio Inc. is a mid-cap company. The stock currently trades at $5.84, down 1.18% today, with a 52-week range of $1.54–$9.75. The company trades at a forward P/E of 33.4x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-0.60 | $-0.60 | +71.6% | |
| 2024 | $-2.11 | $-2.11 | -502.9% | |
| 2023 | $-0.35 | $-0.35 | +27.1% | |
| 2022 | $-0.48 | $-0.48 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-03-02 | 0001193125-26-085584 | SEC ↗ |
| 2024-12-31 | 2025-03-06 | 0000950170-25-034903 | SEC ↗ |
| 2023-12-31 | 2024-02-29 | 0000950170-24-023247 | SEC ↗ |
| 2022-12-31 | 2023-03-15 | 0000950170-23-008180 | SEC ↗ |
| 2021-12-31 | 2022-02-28 | 0000950170-22-002332 | SEC ↗ |
| 2020-12-31 | 2021-03-11 | 0001193125-21-077880 | SEC ↗ |